Novo’s Obesity Drug Arrives in UK – at a Fraction of US Prices

People struggling to lose weight in the UK are finally able to get their hands on the weight-loss drug Wegovy – at a fraction of the costs facing US patients.

But most who have signed up to take the weekly self-injections will remain on the waiting list for some time, as only limited supplies have been released by Novo Nordisk in a “controlled and limited launch.”

The prescription medication, which reduces appetite and cravings, is being marketed for between £199 ($251) and £299 ($377) a month depending on the dosage by Boots — part of Walgreens Boots Alliance Inc. — ...